Literature DB >> 2563055

Impact of an essential drugs programme on availability and rational use of drugs.

H V Hogerzeil1, G J Walker, A O Sallami, G Fernando.   

Abstract

Availability and rational use of drugs was assessed in a random sample of 19 peripheral health units in two governorates in Democratic Yemen in which an essential drugs programme has been operational for the past few years. Findings were compared with those from seven health units in one governorate in which no such programme had been started. On average, 27 essential drugs were available in the programme area, compared with 17 in the control area. Programme areas carried on average 1 non-essential drug, compared with 17 in control areas. Average stock was adequate for 4 weeks in programme areas and for 1 week in control areas. Health workers in the programme area scored slightly, but not significantly, better in a test on theoretical knowledge on rational drug use. However, programme areas differed considerably from control areas in patterns of drug use, with fewer injections (24.8% vs 57.8% of prescriptions) and fewer antibiotics (46.3% vs 66.8%) being prescribed in programme areas, which also had fewer drugs per prescription (1.5 vs 2.4). The programme has significantly improved the availability and rational use of essential drugs in peripheral health units.

Keywords:  Arab Countries; Asia; Comparative Studies; Delivery Of Health Care; Democratic Yemen; Developing Countries; Distributional Activities; Drugs; Equipment And Supplies; Evaluation; Health; Health Facilities; Health Personnel; Health Services; Health Services Evaluation; Knowledge; Organization And Administration; Prescriptions; Program Activities; Program Evaluation; Programs; Qualitative Evaluation; Research Methodology; Research Report; Rural Health Centers; Rural Health Services; Studies; Treatment; Western Asia

Mesh:

Substances:

Year:  1989        PMID: 2563055     DOI: 10.1016/s0140-6736(89)91152-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  18 in total

1.  General physicians and prescribing pattern in isfahan, iran.

Authors:  Leila Safaeian; Ali-Reza Mahdanian; Mansoor Hashemi-Fesharaki; Soolmaz Salami; Javad Kebriaee-Zadeh; Gholam-Hossein Sadeghian
Journal:  Oman Med J       Date:  2011-05

2.  Drug utilisation patterns in the Third World.

Authors:  J S Bapna; C D Tripathi; U Tekur
Journal:  Pharmacoeconomics       Date:  1996-04       Impact factor: 4.981

3.  Paediatric prescribing in out-patient care. An example from Sri Lanka.

Authors:  G Tomson; V Diwan; I Angunawela
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

4.  The case for an essential medicines list for Canada.

Authors:  Gina Eom; Paul Grootendorst; Jacalyn Duffin
Journal:  CMAJ       Date:  2016-06-13       Impact factor: 8.262

5.  Use of Prescription Drugs and Investigations by Doctors in Primary Care Settings in Oman and the UK.

Authors:  Robin Davidson
Journal:  Sultan Qaboos Univ Med J       Date:  2016-11-30

Review 6.  Promoting rational prescribing: an international perspective.

Authors:  H V Hogerzeil
Journal:  Br J Clin Pharmacol       Date:  1995-01       Impact factor: 4.335

Review 7.  Risk factors for acquisition of multiply drug-resistant gram-negative bacteria.

Authors:  I M Gould
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994       Impact factor: 3.267

8.  Drug utilization at primary health care level in southern India.

Authors:  J S Bapna; U Tekur; B Gitanjali; C H Shashindran; S C Pradhan; M Thulasimani; G Tomson
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

9.  Medicine utilization review at a university teaching hospital in New Delhi.

Authors:  M Aqil; V Bhadana; M S Alam; K K Pillai; P Kapur
Journal:  J Pharm Bioallied Sci       Date:  2012-07

10.  Cross sectional surveillance of drug dispensing efficacy, availability and quality of labelling by patient care indicators in health care facilities.

Authors:  Lukshmy M Hettihewa; Kalana Jayarathna; Sewwandi Subasinghe
Journal:  J Pharmacol Pharmacother       Date:  2013-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.